Number of the records: 1  

Labelled compounds as radiopharmaceuticals for radiosynoviorthesis

  1. 1.
    SYSNO ASEP0328173
    Document TypeJ - Journal Article
    R&D Document TypeJournal Article
    Subsidiary JČlánek ve WOS
    TitleLabelled compounds as radiopharmaceuticals for radiosynoviorthesis
    Author(s) Melichar, František (UJF-V) RID
    Kropáček, Martin (UJF-V) RID
    Šrank, Jiří (UJF-V) RID
    Beran, Miloš (UJF-V)
    Mirzajevová, Marcela (UJF-V)
    Zimová, Jana (UJF-V) RID
    Eigner-Henke, Kateřina (UJF-V) RID
    Forsterová, Michaela (UJF-V)
    Source TitleJournal of Radioanalytical and Nuclear Chemistry. - : Springer - ISSN 0236-5731
    Roč. 280, č. 2 (2009), s. 353-358
    Number of pages6 s.
    Action2nd International Nuclear Chemistry Congress (2nd-INCC)
    Event date13.04.2008-17.04.2008
    VEvent locationCancun
    CountryMX - Mexico
    Event typeWRD
    Languageeng - English
    CountryHU - Hungary
    KeywordsRHEUMATOID-ARTHRITIS ; RADIATION SYNOVECTOMY ; FOLLOW-UP
    Subject RIVFR - Pharmacology ; Medidal Chemistry
    R&D ProjectsOE08018 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    2A-1TP1/055 GA MPO - Ministry of Industry and Trade (MPO)
    2B06165 GA MŠMT - Ministry of Education, Youth and Sports (MEYS)
    CEZAV0Z10480505 - UJF-V (2005-2011)
    UT WOS000265714000026
    AnnotationRadiopharmaceuticals for radiosynoviorthesis are designed as suspension (colloidal) of particles in sterile and pyrogen free form, where radionuclide (active substance) fix on carrier which is form solid particles or gel form. Generally, radionuclide and carrier have to fulfil the request of sterility, chemical purity, non toxicity, non allergen and low cost preparation. In term of the radionuclide purity, beta-emission with sufficient energy for penetration and ablation the synovial tissue and low gamma-radiation is requested. The radionuclide gold-198 in colloidal form was used as radiopharmaceutical for radiosynoviorthesis at first. Presently, beta-emitting radionuclides, which have no or only a minimal gammaemission, are used.
    WorkplaceNuclear Physics Institute
    ContactMarkéta Sommerová, sommerova@ujf.cas.cz, Tel.: 266 173 228
    Year of Publishing2010
Number of the records: 1  

  This site uses cookies to make them easier to browse. Learn more about how we use cookies.